Results: 10

Antifungal activity of silver nanoparticles and clotrimazole against Candida spp

Abstract The aim of present study was calculate the Minimum inhibitory concentrations (MICs) of silver nanoparticles and clotrimazole for Candida species and their interaction by the adaptation of standarized methods. The MICs values of clotrimazole were 9 E-04-3 E-03 ug/ml, 0.1-0.6 ug/ml, 3 E-03- 0.1 ug...

Evaluación de susceptibilidad en cándidas spp por colorimetría obtenida en gestantes de un hospital obstétrico

Vive (El Alto); 3 (9), 2020
INTRODUCCIÓN: las infecciones fúngicas ocasionadas por levaduras del género Cándida son extremadamente comunes en mujeres de edad reproductiva, y constituyen un motivo de atención medica de salud. OBJETIVO: evaluar la susceptibilidad de Cándidas spp, mediante el método colorimétrico (Integral Yea...

Efficacy of topical clotrimazole vs. topical tolnaftate in the treatment of otomycosis. A randomized controlled clinical trial

Abstract Introduction: Otomycosis, an infection of the ear canal by fungi, is prevalent in hot and humid weather. Nevertheless, there is not sufficient evidence for the effectiveness of different topical antifungal treatments. Tolnaftate, is a topical antifungal agent described to be effective in the tr...

Diphenyl Diselenide and Clotrimazole Co-loaded into Eudragit® RS 100 Nanocapsules Formulation Has Superior Antioxidant Potential and Promising Anti-candida Activity

Abstract In the current study, nanocapsules (NC) formulations containing a co-load of clotrimazole (C), a highly prescribed antifungal drug, and diphenyl diselenide [(PhSe)2], an organoselenium compound with a promising scope of pharmacological actions, were prepared. Formulations were characterized as w...

Comparison of the recovery rate of otomycosis using betadine and clotrimazole topical treatment

Abstract Introduction Otomycosis is a common diseases that can be associated with many complications including involvement of the inner ear and mortality in rare cases. Management of otomycosis can be challenging, and requires a close follow-up. Treatment options for otomycosis include local debridement...

Modulation of the oxidative stress in malaria infection by clotrimazole

Braz. j. pharm. sci; 48 (3), 2012
Antimycotic clotrimazole (CTZ) has demonstrated remarkable activity against Plasmodium falciparum in vitro and in vivo. Hemoglobin degradation by Plasmodium parasites makes amino acids available for protein synthesis, inducing oxidative stress in infected cells and producing free heme. These events repre...

Avaliaçäo clínica e laboratorial de uma associaçäo nimorazol - clotrimazol - lisozima, em creme vaginal, em vulvovaginites por Gardnerella vaginalis
Clinical and laboratorial evaluation of a nimorazol - clotrimazol - lysozyme vaginal cream, on vulvovaginitis by Gardnerella vaginalis

J. bras. ginecol; 99 (9), 1989

Tratamento das vulvovaginites por tricomoníase e candidíase com associaçäo nimorazol/clotrimazol/lisozima na forma de creme vaginal
Treatment of vulvovaginal trichomoniasis and candidiasis with a combination of nimorazole, clotrimazole, and lysozyme in the form of vaginal cream

Arq. bras. med; 61 (3), 1987
Estudou-se a atividade da associaçäo nimorazol/clotrimazol/lisozima na forma de creme vaginal, por seis noites consecutivas, em 36 pacientes portadoras de vulvovaginites causadas por Trichomonas vaginalis e/ou Candida albicans. Tratavam-se concomitantemente os parceiros de pacientes portadoras de trico...

Estudo clínico de uma associaçäo nimorazol-clotrimazol-lisozima, em creme vaginal, em vulvovaginites por Haemophylus vaginalis e outros microorganismos, por seis dias de tratamento
Clinical study of nimorazol-clotrimazol-lysozyme combinations, in vaginal cream, in vulvovaginitis by Haemopilus vaginal and other microorganisms, in a 6 day treatment

Arq. bras. med; 60 (3), 1986
Estudou-se um grupo de 30 pacientes de sexo feminino, com idades entre 19 e 43 anos, näo virgens, com vida sexual ativa ou näo, portadoras de vulvovaginites por Haemophylus vaginalis. Todos os casos apresentaram concomitantemente Trichomonas vaginalis e/ou Candida albicans. O tratamento foi feito em 6 ...